Aspen Neuroscience Plans IPO of Nearly 9.4 Million Shares
Aspen Neuroscience plans to sell nearly 9.4 million shares at $15 to $17 each. At the $16 midpoint, the company expects net proceeds of about $134.5 million.
By Colin KellaherAspen Neuroscience plans to sell nearly 9.4 million shares at between $15 and $17 each in its initial public offering.At the $16 midpoint of that price range, the San Diego, California, clinical-stage biotechnology company said it expects net proceeds of about $134.5 million, or ro…